Back
Kymera Therapeutics Stock Predictions
Sponsored
KYMR
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
KYMR
Kymera Therapeutics
Last Price:
44.98
Seasonality Move:
21.35%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Kymera Therapeutics Stock Forecast
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 13.2% based on the past 4 years of stock performance.
- Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Kymera Therapeutics Stock Undervalued?
The current Kymera Therapeutics [KYMR] share price is $44.98. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal. - KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Kymera Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 13.2% based on the past 4 years of stock performance.
Kymera Therapeutics Stock Rating
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics overpriced?
- Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Kymera Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com
52-Week Data
52-Week High:
53.27
52-Week Low:
18.89
Prediction Charts
Market Cap:
2.91B
Price in USD:
44.98
Volume:
559.06K
Beta:
2.19
Technical Analysis
SMA50:
46.95
SMA100:
45.26
SMA200:
40.89
52-Wk Change:
127.86%
Stock Predictions
-
Is Kymera Therapeutics stock public?
Yes, Kymera Therapeutics is a publicly traded company. -
What is the Kymera Therapeutics stock quote today?
The Kymera Therapeutics stock price is 44.98 USD today. -
How to buy Kymera Therapeutics stock online?
You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-5 | 46.98 | 47.69 | 48.88 | 46.35 |
Nov-6 | 49.93 | 49.52 | 51.14 | 48.47 |
Nov-7 | 49.52 | 49.86 | 50.99 | 48.58 |
Nov-8 | 49.91 | 50.94 | 51.13 | 49.39 |
Nov-11 | 51.97 | 51.83 | 53.23 | 51.45 |
Nov-12 | 51.49 | 50.05 | 52.49 | 49.12 |
Nov-13 | 50.79 | 48.63 | 51.15 | 48.63 |
Nov-14 | 48.70 | 45.95 | 49.09 | 45.89 |
Nov-15 | 45.00 | 41.96 | 45.45 | 41.50 |
Nov-18 | 42.03 | 42.41 | 43.08 | 41.12 |
Nov-19 | 42.09 | 42.84 | 42.89 | 41.50 |
Nov-20 | 42.75 | 44.05 | 44.11 | 42.10 |
Nov-21 | 44.05 | 43.51 | 44.81 | 42.87 |
Nov-22 | 43.70 | 44.98 | 45.94 | 43.28 |
Kymera Therapeutics Earnings
Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kymera Therapeutics Forecast Revenue Growth
Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.51 per share.
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.